Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia | BMC Cancer | Full Text
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Thumbnails — IMDC | International mRCC Database Consortium
Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib | NEJM
Survival after complete surgical resection of multiple metastases from renal cell carcinoma - Alt - 2011 - Cancer - Wiley Online Library
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma | NEJM
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial | Nature Medicine
Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - Annals of Oncology
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Overall survival of 124 patients who initially received cytokines... | Download Scientific Diagram
Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram
Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram
Frontiers | Causes of Death and Conditional Survival of Renal Cell Carcinoma
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis
Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
xmlinkhub
Renal Cell Cancer Treatment (PDQ®)–Health Professional Version - NCI
Overall survival rates of 95 patients with metastatic renal cell... | Download Scientific Diagram
